N/A
N=50
Diet and Hereditary Haemorrhagic Telangiectasia
Hereditary Haemorrhagic Telangiectasia (HHT)
Bottom Line
View on ClinicalTrials.gov: NCT01692015 ↗Enrolled (actual)
50
Serious AEs
0.0%
Results posted
Mar 2024
Primary outcome: Primary: Number of Participants That Achieving Personal Recommended Intake of Iron — 43 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Questionnaire on dietary history (Other); Questionnaire on nosebleed severity (Other); One week food diary generated by weighing foods (Other); Blood tests for full blood count, albumin, and indices of nutritional status (Procedure)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Imperial College London
- Primary completion
- Sep 2013
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants That Achieving Personal Recommended Intake of Iron |
43 | — |
| PRIMARY Nosebleed Severity |
4.4 | — |
| PRIMARY Number of Participants That Achieving the Hemorrhage Adjusted Iron Requirement (HAIR) |
10 | — |
Summary
Hereditary Haemorrhagic Telangiectasia (HHT) affects 1 in 5,000 people. The purpose of this study is to provide data regarding the diet and nosebleed frequency using a questionnaire.
This will be filled in by people with HHT.
The questionnaire has been designed in paper format.
Eligibility Criteria
Inclusion Criteria
- A diagnosis of hereditary Haemorrhagic Telangiectasia (HHT)
Exclusion Criteria
- Unable to provide informed consent
- Presence of another major organ disorder that may affect nutritional status, such as inflammatory bowel disease, or celiac disease.
Data sourced from ClinicalTrials.gov (NCT01692015). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.